Barbara Stricker-Friedman, MD
Obstetrics & Gynecology · Attleboro, MANPI 1972553121
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 27.2% of the total. Reporting peaked in 2019 at $2,768 and has fallen 58.2% since, to $1,158 in 2025. Among obstetrics & gynecology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $57.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Coloplast$2K
- Minerva Surgical, Inc$429
- AbbVie$390
- Astellas Pharma US Inc$387
- plus $2K from 16 others
What the payments were for
- Travel & lodging$3,93748%
- Food & beverage$3,87347%
- Education$3965%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $2,230 |
| Boston Scientific | 7 | $1,666 |
| Coloplast | 11 | $1,552 |
| Minerva Surgical, Inc | 17 | $429 |
| AbbVie(2 entities) | 17 | $390 |
| Astellas Pharma US Inc | 13 | $387 |
| Sumitomo Pharma America, Inc. | 14 | $290 |
| Exeltis, USA Inc. | 6 | $261 |
| Intuitive Surgical | 5 | $240 |
| Axonics, Inc. | 4 | $164 |
| Hologic Sales And Service, LLC | 1 | $129 |
| Therapeuticsmd, Inc. | 5 | $101 |
| Pfizer | 7 | $95 |
| Bayer | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Avion Pharmaceuticals | 3 | $43 |
| 180 Medical, Inc. | 1 | $28 |
| Covidien LP | 2 | $26 |
| Amgen | 1 | $22 |
| Lupin Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,462
- INTERSTIM$1,242
- AMS 700 CXR RTE KIT$691
- UPSYLON$652
- SOLYX$264
- Axonics$143
- ACESSA PROVU SYSTEM$129
- Da Vinci Surgical System$117
- Veozah$109
- Slynd$102
How this compares
$8,206 in reported general payments places this provider in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 312 | $190,521 |
| GemtesaVibegron | 78 | $79,185 |
| Mirabegron ErMirabegron | 23 | $15,327 |
| Estradiol | 174 | $15,188 |
| YuvafemEstradiol | 55 | $9,492 |
| Trospium Chloride ErTrospium Chloride | 20 | $5,180 |
| Estradiol (Twice Weekly)Estradiol | 42 | $5,015 |
| Trospium Chloride | 47 | $3,577 |
| Clobetasol Propionate | 40 | $3,458 |
| Clindamycin Phosphate | 22 | $1,944 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $1,052 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $739 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 78 | $637 |
| ProgesteroneProgesterone, Micronized | 17 | $616 |
| Fluconazole | 49 | $268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $387 | $190,521312 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $290 | $79,18578 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 910 obstetrics & gynecology providers in Massachusetts.
Other obstetrics & gynecology in Attleboro
- Soheil Amin HanjaniBrockton$386K
- Joelle LiemanBrighton$215K
- Elizabeth OnyemelukweBoston$135K
- James GreenbergBoston$119K
- Stephanie AlimenaBoston$75K
- Denis VaughanBoston$38K
- Lara KingstonPlymouth$37K
- Erica RobinsonWorcester$32K
- Roxanne GardnerBoston$31K
- James WangSpringfield$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.